Dutch guidelines for diagnosis and treatment of chronic lymphocytic leukaemia 2011

Neth J Med. 2011 Oct;69(10):422-9.

Abstract

One of the principal responsibilities of the Chronic Lymphocytic Leukaemia (CLL) Working Party of the Dutch/Belgium Haemato-Oncology Foundation for Adults in the Netherlands (HOVON) is to create up-to-date guidelines for CLL . In this article, the revised guidelines for diagnosis and treatment are summarised. Despite recent expansion in treatment options for patients with CLL , the disease remains incurable in most cases and the optimal treatment approach for several subgroups of patients is still unclear. Therefore, it remains highly important to treat patients within clinical studies as much as possible. In this article, the current studies initiated by the HOVON CLL working party are emphasised.

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis*
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
  • Netherlands
  • Recurrence

Substances

  • Antineoplastic Agents